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ABSTRACT
Background: Regulated on activation, normal T expressed and secreted (RANTES) has been known to be
deeply involved in the pathophysiology of atopic dermatitis (AD). To examine whether a −401AG polymor-
phism in the RANTES promoter gene is associated with the susceptibility to AD in Japanese, we determined
the genotypes of the polymorphism in 145 Japanese students and 65 patients with AD.
Methods: DNA was isolated from the mononuclear cells by using SepaGene (Sanko) and analyzed by the po-
lymerase chain reaction (PCR) technique.
Results: The frequency of −401A allele was 0.39 in the healthy subjects without AD. This was not significantly
different from that in the patients with AD (0.41). We also failed to show association between the polymorphism
in the RANTES promoter gene and the production of IgE.
Conclusions: These results suggest that the −401AG polymorphism in the RANTES promoter gene does
not determine the susceptibility to AD in Japanese, although larger studies could explore the exact role of the
polymorphisms in AD, or Japanese might have other susceptibility genes more potent than the RANTES pro-
moter gene.
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INTRODUCTION
Chemotactic cytokines (chemokines) are small sig-
naling proteins , which are deeply involved in the
physiology and pathophysiology of acute and chronic
inflammatory processes by attracting and stimulating
specific subsets of leukocytes.1 The chemokines are
divided into four groups , CXC chemokine , C-C
chemokine, CX3C chemokine and C chemokine by
their molecular structure. Among the C-C chemoki-
nes, regulated on activation, normal T expressed and
secreted (RANTES) has been considered to play a
crucial role in allergic diseases because of its potent
activity for attracting eosinophils and memory T cells.
In fact, an enhanced production of RANTES was dem-
onstrated in many of the allergic diseases suggesting
the involvement of the chemokine in the pathogene-
sis of these diseases.2-5 Recently, a single-nucleotide
mutation in the RANTES promoter gene (−401AG,
refSNP ID: rs2107538) has been reported to affect the
transcriptional-rate of the gene by constructing an ad-
ditional binding site of GATA transcription factor, and
this gain-of-mutation function has been shown to be
associated with atopic dermatitis (AD) in German
children. In the human mast cell line HMC-1 and the
T cell line the −401A allele was shown to have higher
promoter activity of the RANTES gene compared
with the more frequent allele −401G, suggesting that
overproduction of RANTES underlies the develop-
ment of AD. However, great differences in the fre-
quency of −401A allele were also reported among
races.6
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Table 1 Distribution of RANTES promotor genotypes (－401A/G) and total serum IgE*
Frequency
of A
Genotype
NumberSubjects
GGAGAA
IgE
(mean ± SD)
Number
IgE
(mean ± SD)
Number
IgE
(mean ± SD)
Number
0.41 3.80 ± 0.58223.66 ± 0.64334.08 ± 0.561065AD
0.20 2.33 ± 0.57182.60 ± 0.72 91.146 128Students (with AD)
0.39 2.00 ± 0.66422.07 ± 0.64592.13 ± 0.6116117Students (without AD)
*data was expressed as log (IgE)
In order to ascertain the frequency of −401A allele
in the RANTES promoter gene and to investigate
whether the polymorphism determines susceptibility
to AD in Japanese, the genotypes of the RANTES
−401AG polymorphism in 65 patients with AD and
145 students who had been randomly selected, were
determined and the relation between AD and geno-
type was analyzed.
METHODS
SUBJECTS
Sixty-five patients with AD who were being treated at
the Hiroshima University Hospital Department of
Dermatology and 145 students of the Hiroshima Uni-
versity Faculty of Medicine were enrolled in the
study. The patients with AD were aged 18 to 50 years,
and the students were aged 22 to 30 years. The diag-
nosis of AD was made using the criteria of the Japa-
nese Dermatological Association.7 Informed consent
was obtained from all subjects according to the crite-
ria established by the ethics committee of Hiroshima
University. Total serum IgE and specific IgE antibod-
ies for cedar pollen, candida, pityrosporium, dermato-
phagoides farinae, wheat and rice in serum were de-
termined by a fluoroenzyme immunoassay (CAP sys-
tem, Pharmacia Upjohn, Uppsala, Sweden).8
GENOTYPING OF RANTES GENE
Mononuclear cells were separated from 2 ml of anti-
coagulated peripheral blood. DNA was isolated from
the mononuclear cells by using SepaGene (Sanko)
and analyzed by the polymerase chain reaction (PCR)
technique. The PCR mixture (in a volume of 50 μl)
contained 160 μM of dNTPs, 1 μM of specific primer
(see below), 1 unit of Taq DNA polymerase and 1 μl
of DNA sample. Primers were as follows: the sense
primers for RANTES were − 401 A 5 ’ -
CATGGATGAGGGAAAGGAGA-3 ’ and − 401 G 5 ’ -
CATGGATGAGGGAAAGGAGG-3’, and the antisense
primer was 5 ’ -ATCCTCTGCAGGAATCCTCTG-3 ’ .
The reaction conditions were: denaturation, 94℃, 1
minute; annealing, 62℃, 2 minutes; extension, 72℃,
3 minutes for 35 cycles in a DNA thermal cycle (MIR-
D40, Sanyo).
The PCR product (5 μl) was mixed with 1 μl dye so-
lution (1% SDS, 50% glycerol and 0.05% bromophenol
blue) and electrophoresed in 2.5% agar gels in 1 ×
TAE buffer (40 mM Tris , 8 mM acetate , 0.4 mM
EDTA) at a constant 100 V for 1 hour. Products were
visualized by ethidium bromide over a UV transillu-
minator and then photographed.
STATISTICAL ANALYSIS
Wilcoxon nonparametric tests were performed to as-
sess differences in the total serum IgE levels of the
subject groups. The χ2 test was used to determine the
significance in the frequency of −401A allele of the
RANTES promoter gene among the subject groups.
RESULTS
In our study, 28 subjects of 145 students were diag-
nosed as having or having had AD, and 117 subjects
were found to have neither symptoms nor a history of
AD. The distribution of RANTES promoter genotypes
(−401AG) is shown in Table 1. Frequency of −401A
allele of the RANTES promoter gene in the subjects
without AD (n = 117) was 0.39, and that in the pa-
tients with AD was 0.41. There was no significant dif-
ference in the allele frequency between the subjects
without AD and the AD patients (p = 0.93).
To investigate the influence on serum IgE levels of
the genotype, total serum IgE levels were compared
among the genotypes (Table 1). There was no signifi-
cant difference among the genotypes in the patients
with AD or in the students without AD (p = 0.99), al-
though the levels of total serum IgE in the patients
with AD were significantly higher than those found in
the students . The influence of the genotypes on
antigen-specific IgE production was also examined in
the students (n = 145). Table 2 shows the distribution
of RANTES promoter-genotypes in antigen-specific
IgE-positive and negative groups. There was no sig-
nificant difference in frequency of the polymorphisms
of the RANTES promoter gene in any group.
DISCUSSION
In the present study, we found that the frequency of
the mutated gene was 0.35 in Japanese students. This
was higher than that in Caucasians (0.14) and Colom-
bians (0.30), but lower than that in African Americans
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Table 2 Distribution of RANTES promotor genotypes (−401A/G) in antigen-specific IgE-positive and negative groups
Frequency of A
Genotype
numberspecific IgEantigen
GGAGAA
0.33 3737 9 83(＋)cedar
0.38 2331 8 62(−)
0.26  9 7 1 17(＋)candida 
0.36 516116128(−)
0.30  5 4 1 10(＋)pityrosporium 
0.36 556416135(−)
0.38 304011 81(＋)dermatophagoides farinae
0.31 3028 6 64(−)
0.21  8 3 1 12(＋)wheat
0.36 526516133(−)
0.20  7 2 1 10(＋)rice
0.36536616135(−)
(0.43) and Afro-Caribbeans (0.44).6 Because the stu-
dents were randomly selected and contained subjects
with AD and a history of AD, the frequency of the
mutated gene was then recalculated in the subjects
without AD and a history of AD. The frequency in the
healthy subjects was 0.39, and this was not signifi-
cantly different from that in the patients with AD (Ta-
ble 1). This supports the data obtained by Kozma et
al. who calculated the frequency of −401A allele for
0.18 in Hungarian AD patients, and this was not sig-
nificantly different from that in Hungarian children
without allergic disorders.9 Our results also showed
that −401AG polymorphism of the RANTES pro-
moter gene is not associated with total serum IgE lev-
els and production of antigen-specific IgE in Japanese
subjects.
Recently , a promoter gene polymorphism of an-
other C-C chemokine , thymus and activation-
regulated chemokine (TARC), was shown to be a
gain-of-function mutation.10 In fact, a single nucleo-
tide polymorphism in the 5 ’ -flanking region of the
TARC gene (−431CT) was reported to be associated
with serum levels of TARC in patients with AD. 10
However, in Japanese, no significant difference was
found in the allele frequencies between AD patients
and controls. These results suggest that the -431CT
polymorphism in the TARC gene is not associated
with the susceptibility to AD in Japanese population,
either.11
The discrepancy in the data among these counties
is unclear at the moment. Since AD develops as a cu-
mulative effect of genetic factors and environmental
factors, we might consider the difference in environ-
mental factors between Europe and Asia: a possibility
that there are not enough environmental factors to
trigger the production of RANTES in Japan. This is
unlikely because we have almost the same frequency
of AD patients in Japan as in European countries.12,13
The results obtained in this study suggest that the
−401AG polymorphism in the RANTES gene does
not determine the susceptibility to AD in Japanese, al-
though larger studies could explore the exact role of
the polymorphism on the development of AD in Japa-
nese. Japanese might have other genes that predomi-
nantly influence the susceptibility to AD to a greater
extent than the RANTES promoter gene.
AD develops mostly in families with atopic diathe-
sis together with allergic rhinitis and allergic bron-
chial asthma. Atopic diathesis is a complex genetic
background characterized by the excessive produc-
tion of total and allergen-specific IgE. Involvement of
genetic factors in the development of AD was clearly
determined by a twin-study performed by Larsen et al. 14
Monozygotic twins run a risk of 0.86 of having AD if
the twin partner has the disease, whereas the disease
risk of 0.21 by dizygotic partners does not differ from
the frequency seen in ordinary brothers and sisters.14
A great deal of investigation has focused on polymor-
phisms in the genome to clarify the genetic back-
ground susceptibility to AD including genes for
FcεRI-β,15 mast cell chymase,16 interleukin-4 (IL-4)17
and IL-4 receptor . 18 However , the associations of
these genes with AD still remain controversial. Fur-
ther studies will be necessary to clarify the genetic
background in AD.
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